Chapter

Evaluation and Management of Pregnancy-Associated Arrhythmias

Peter A. Brady

in Mayo Clinic Cardiology

Fourth edition

Published on behalf of © Mayo Foundation for Medical Education and Research

Published in print November 2012 | ISBN: 9780199915712
Published online May 2013 | e-ISBN: 9780199322824 | DOI: http://dx.doi.org/10.1093/med/9780199915712.003.0614

Series: Mayo Clinic Scientific Press

Evaluation and Management of Pregnancy-Associated Arrhythmias

Show Summary Details

Preview

The presentation and management of heart rhythm disorders arising during pregnancy and lactation are similar to those in nonpregnant patients. However, patients who present with a heart rhythm disorder during pregnancy deserve special consideration. Accurate rhythm diagnosis and assessment of symptom severity (especially hemodynamic symptoms) are mandatory. Arrhythmias that result in hemodynamic compromise (usually in patients with structural heart disease) are of major concern—not only because of potential harm to the mother but also because of potential harm to the fetus through reduced placental blood flow. Risks of antiarrhythmic drug therapy during pregnancy include risk to the mother and risk to the fetus. Cardioversion is safe during pregnancy and should be an early option in the management of arrhythmia, especially in the presence of hemodynamic compromise.

Chapter.  3515 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.